Could expression of co-stimulatory molecules on B-PBL condition the acceptance or rejection of human liver grafts?
Immunology Section, University Hospital "Virgen de la Arrixaca," 30120, Murcia, Spain.
A
A
Minguela
F
F
Sánchez-Bueno
L
L
Marín
M
M
Miras
J A
JA
Pons
M
M
Muro
A
A
Torío
A M
AM
García-Alonso
R
R
Robles
P
P
Parrilla
P
P
Ramirez
M R
MR
Alvarez-López
D000069594:Abatacept; D000938:Antigen-Presenting Cells / Q000276:immunology*; D015703:Antigens, CD / Q000378:metabolism; D000943:Antigens, Differentiation / Q000276:immunology / Q000378:metabolism*; D018122:B7-1 Antigen / Q000276:immunology / Q000378:metabolism*; D051940:B7-2 Antigen; D018106:CD28 Antigens / Q000276:immunology / Q000378:metabolism*; D060908:CTLA-4 Antigen; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D018796:Immunoconjugates; D016031:Liver Transplantation / Q000276:immunology*; D008562:Membrane Glycoproteins / Q000378:metabolism; D023001:Transplantation Tolerance / Q000276:immunology*
D015703:Antigens, CD; D000943:Antigens, Differentiation; D018122:B7-1 Antigen; D051940:B7-2 Antigen; D018106:CD28 Antigens; C497964:CD86 protein, human; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018796:Immunoconjugates; D008562:Membrane Glycoproteins; D000069594:Abatacept